We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Kowa Co Ltd (7807) - Financial and Strategic SWOT Analysis Review

Published: April 2019
Pages: 36
Code: 1F24BFC98B390567EF10BF6BB8DF227F
Format: PDF
Publisher GlobalData
From Add to basket
$ 125.00
Provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Additonal Information

  • - Business description – A detailed description of the company’s operations and business divisions.
  • - Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • - Company history – Progression of key events associated with the company.
  • - Major products and services – A list of major products, services and brands of the company.
  • - Key competitors – A list of key competitors to the company.
  • - Key employees – A list of the key executives of the company.
  • - Executive biographies – A brief summary of the executives’ employment history.
  • - Key operational heads – A list of personnel heading key departments/functions.
  • - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • - Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
  • Highlights
  • Kowa Co Ltd (Kowa) manufactures over the counter (OTC) products, ethical drugs and medical equipment; imports and exports LED lighting equipment, optical equipment and renewable energy power generation systems; and trading of textile, life style products, construction materials, machinery, chemicals and commodities. The company also trades various items, such as pharmaceutical ingredients, ingredients for cosmetics, monomers and specialty chemicals, oil and fats, feed additives, activated carbon and coal, industrial machinery and equipment and vessels. The company operates through its subsidiaries and affiliates across Japan, North America, Latin America, Europe, Asia and Oceania. Kowa is headquartered in Nagoya, Aichi, Japan.
  • Kowa Co Ltd Key Recent Developments
  • Apr 30,2018 SQM Announces End of Controller Group Agreement

Companies Mentioned

Takeda Pharmaceutical Co Ltd
Taiho Pharmaceutical Co Ltd
Summit Pharmaceuticals International Corp
Senju Pharmaceutical Co Ltd
Novaferm AB
Maruho Co Ltd
Janssen Pharmaceutical KK
Hayashibara Co Ltd
Daiichi Sankyo Co Ltd

Reasons to buy

You get detailed information about the company and its operations to identify potential customers and suppliers. The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company
Add to basket
  • Table of Contents
  • Table of Contents
  • List of Tables
  • List of Figures
  • Section 1 - About the Company
  • Kowa Co Ltd - Key Facts
  • Kowa Co Ltd - Key Employees
  • Kowa Co Ltd - Key Employee Biographies
  • Kowa Co Ltd - Major Products and Services
  • Kowa Co Ltd - History
  • Kowa Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
  • Section 2 – Company Analysis
  • Company Overview
  • Kowa Co Ltd - Business Description
  • Kowa Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Kowa Co Ltd - Strengths
  • Kowa Co Ltd - Weaknesses
  • Kowa Co Ltd - Opportunities
  • Kowa Co Ltd - Threats
  • Kowa Co Ltd - Key Competitors
  • Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Kowa Co Ltd, Recent Deals Summary
  • Section 5 – Company’s Recent Developments
  • Apr 30, 2018: SQM Announces End of Controller Group Agreement
  • Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About GlobalData
  • Contact Us
  • Disclaimer
  • List of Tables
  • Kowa Co Ltd, Key Facts
  • Kowa Co Ltd, Key Employees
  • Kowa Co Ltd, Key Employee Biographies
  • Kowa Co Ltd, Major Products and Services
  • Kowa Co Ltd, History
  • Kowa Co Ltd, Other Locations
  • Kowa Co Ltd, Subsidiaries
  • Kowa Co Ltd, Joint Venture
  • Kowa Co Ltd, Key Competitors
  • Kowa Co Ltd, Ratios based on current share price
  • Kowa Co Ltd, Annual Ratios
  • Kowa Co Ltd, Annual Ratios (Cont...1)
  • Kowa Co Ltd, Annual Ratios (Cont...2)
  • Kowa Co Ltd, Interim Ratios
  • Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Kowa Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
  • List of Figures
  • Kowa Co Ltd, Performance Chart (2016 - 2018)
  • Kowa Co Ltd, Ratio Charts
  • Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019